Postpartum Depression Epidemiology Forecast 2025-2034

Postpartum depression is a severe mood disorder, affecting around 1 in 7 women within the first year following childbirth. Despite its substantial prevalence, nearly 50% of the cases remain undiagnosed as a result of the stigma associated with the condition and reluctance among the patients to disclose symptoms.

Postpartum Depression Epidemiology Forecast Report Coverage

The “Postpartum Depression Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of postpartum depression. It projects the future incidence and prevalence rates of postpartum depression across various populations. The study covers age and type as major determinants of the postpartum depression-affected population. The report highlights patterns in the prevalence of postpartum depression over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of postpartum depression in the 8 major markets.

Regions Covered

• The United States
• EU-4 (Germany, France, Italy, Spain) and the United Kingdom
• Japan
• India

Postpartum Depression: Disease Overview

Postpartum depression refers to a serious mental health condition that is prevalent among women after giving birth. It can occur anytime within the first year post childbirth but is usually reported to begin within the first month. This mood disorder can be caused by several factors such as hormonal changes and genetic predisposition. Common symptoms include persistent sadness, difficulty bonding with the baby, sleep disturbances, anxiety, and low self-esteem, among others. Postpartum depression is more severe than baby blues which typically go away within a few days.

Postpartum Depression: Treatment Overview

A combination of medical, psychological, and supportive approaches is usually found to be effective in treating postpartum depression in new mothers. Selective serotonin reuptake inhibitors (SSRIs), like sertraline or paroxetine, are commonly prescribed antidepressants that are considered safe for breastfeeding mothers. Psychotherapy such as cognitive behavioral therapy (CBT) is also recommended to patients to identify and change negative thought patterns and behaviors that contribute to depression.

Epidemiology

The Postpartum Depression epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for postpartum depression by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for postpartum depression and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• The global prevalence of postpartum depression, one of the most common complications linked with pregnancy, is estimated to be 17.22%, as per Wake et al., 2022.
• Around 1 in 7 women experience postpartum depression within the first year following children, with around 50% of cases remaining undiagnosed due to the stigma attached to the condition.
• In a hospital-based cross-sectional study (2024) conducted on 426 women in the sub-Himalayan region in India, the overall prevalence of postpartum depression was estimated to be 17.4%.
• Studies suggest that, on average, the onset of postpartum depression occurs 14 weeks after the mother has given birth. However, Black and Hispanic patients are found to report the onset of symptoms within 2 weeks in contrast to white patients who often report the onset of symptoms later.

Country-wise Postpartum Depression Epidemiology

The postpartum depression epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of postpartum depression differs between countries owing to factors such as cultural, economic, and environmental conditions. Further, healthcare infrastructure, mental health resources, and the presence of support networks also influence the incidence rate of postpartum depression. For instance, in a meta-analysis, the prevalence of postpartum depression in the United States and Japan was reported to be 8.6% and 14%, respectively.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of postpartum depression based on several factors.
• Postpartum Depression Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India)
• The report helps to identify the patient population, and the unmet needs of postpartum depression are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of postpartum depression epidemiology in the 8 major markets?
• What will be the total number of patients with postpartum depression across the 8 major markets during the forecast period?
• What was the country-wise prevalence of postpartum depression in the 8 major markets in the historical period?
• Which country will have the highest number of postpartum depression patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of postpartum depression during the forecast period of 2025-2034?
• What are the currently available treatments for postpartum depression?
• What are the disease risks, signs, symptoms, and unmet needs of postpartum depression?

This product will be delivered within 3-5 business days.